InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
18.24
+0.53 (2.99%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.

The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures.

It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.

The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017.

InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

InMode Ltd.
InMode logo
Country Israel
Founded 2008
IPO Date Aug 8, 2019
Industry Medical Devices
Sector Healthcare
Employees 581
CEO Moshe Mizrahy

Contact Details

Address:
Tavor Building, Sha’ar Yokneam
Yokne'am, 2069206
Israel
Phone 972 4 909 6313
Website inmodemd.com

Stock Details

Ticker Symbol INMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $14.00
CIK Code 0001742692
CUSIP Number M5425M103
ISIN Number IL0011595993
SIC Code 3845

Key Executives

Name Position
Moshe Mizrahy Chief Executive Officer and Director
Yair Malca Chief Financial Officer
Alon Yaari Vice President of Operations
Dr. Michael Kreindel Chief Technology Officer and Director
Nava Tal-Launer Chief Information Officer

Latest SEC Filings

Date Type Title
Oct 30, 2024 6-K Report of foreign issuer
Oct 16, 2024 UPLOAD Filing
Oct 1, 2024 6-K Report of foreign issuer
Sep 30, 2024 UPLOAD Filing
Sep 10, 2024 UPLOAD Filing
Sep 10, 2024 6-K Report of foreign issuer
Aug 1, 2024 6-K Report of foreign issuer
May 2, 2024 6-K Report of foreign issuer
Apr 4, 2024 6-K Report of foreign issuer
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals